Search company, investor...
Moximed company logo

Moximed

moximed.com

Stage

Series C - II | Alive

Total Raised

$196.5M

About Moximed

Moximed is a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The Moximed implants do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company is based in Fremont, California.

Headquarters Location

46602 Landing Parkway

Fremont, California, 94538,

United States

510-887-3300

Missing: Moximed's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Moximed's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Moximed

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Moximed is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Moximed Patents

Moximed has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/21/2019

7/19/2022

Skeletal system, Joints, Orthopedic surgical procedures, Arthritis, Upper limb anatomy

Grant

Application Date

10/21/2019

Grant Date

7/19/2022

Title

Related Topics

Skeletal system, Joints, Orthopedic surgical procedures, Arthritis, Upper limb anatomy

Status

Grant

Latest Moximed News

5 spine, orthopedic medtch investments in 90 days

Oct 27, 2022

Becker's reported on five spine and orthopedic devicemakers landing nearly $200 million in investments since July 29: 1. Devicemaker Moximed has raised $40 million to develop what the company says is the world's first implantable shock absorber for the knee. 2. Xtant Medical entered an agreement to sell common stock and warrants to investors. The investment is expected to be about $9.75 million, and proceeds are expected to help working capital and general corporate purchases. 3. Elevation Spine, a developer of integrated-fixation spinal technologies, on Sept. 22 completed its Series B preferred stock financing, totaling $11 million. 4. Orthobiologics company Ossio closed a $38.5 million series C financing round. 5. Think Surgical raised $100 million from a new investor to accelerate commercialization of its surgical robots.

Moximed Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Moximed Rank

Moximed Frequently Asked Questions (FAQ)

  • Where is Moximed's headquarters?

    Moximed's headquarters is located at 46602 Landing Parkway, Fremont.

  • What is Moximed's latest funding round?

    Moximed's latest funding round is Series C - II.

  • How much did Moximed raise?

    Moximed raised a total of $196.5M.

  • Who are the investors of Moximed?

    Investors of Moximed include New Enterprise Associates, Morgenthaler Ventures, GBS Venture Partners, Gilde Healthcare, Vertex Ventures HC and 9 more.

  • Who are Moximed's competitors?

    Competitors of Moximed include SynCardia Systems, Celonova Biosciences, Lucina Health, Corpora Systems, FluimediX and 13 more.

Compare Moximed to Competitors

N
NeuroTrax

NeuroTrax is a medical device and technology company.

s
synecor

synecor is a medical device developer

C
Cardiola

Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.

C
C2C

C2C is a medical device company developing a portfolio of medical devices.

C
Celonova Biosciences

CeloNova BioSciences is a global medical device company that develops, manufactures and markets a family of interventional cardiology and endovascular products, including its proprietary COBRA PzF Coronary Stent System. The company's interventional cardiology and endovascular products are currently available in more than fifty countries.

ImpediMed Logo
ImpediMed

ImpediMed is a medical device company focusing on bioimpedance.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.